Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China; Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.
Department of Thoracic Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Int J Surg. 2020 Nov;83:206-215. doi: 10.1016/j.ijsu.2020.09.049. Epub 2020 Oct 3.
Studies have provided controversial and limited knowledge regarding the impact of sarcopenia on surgical outcomes in esophageal cancers due to retrospective study designs and single muscle-mass assessment. This prospective cohort study aimed to resolve these issues.
Bioelectrical impedance analysis, handgrip strength measurement, and the 4-m walking test were conducted before surgery. Sarcopenia was diagnosed as low appendicular skeletal muscle mass index (<7.0 kg/m in men and <5.7 kg/m in women) plus low handgrip strength (<26 kg in men and <18 kg in women) and/or low gait speed (<0.8 m/s). Presarcopenia was diagnosed as either: (1) solely low muscle mass index; or (2) solely low handgrip strength and/or gait speed. Endpoints included perioperative biochemical indicators, postoperative complications, and the recovery of postoperative quality of life (QOL).
In total, 212 patients were enrolled, including 55 (25.9%) and 60 (28.3%) patients diagnosed with sarcopenia and presarcopenia, respectively. The presarcopenic and normal patients showed a similar risk of postoperative complications and were combined. Despite similar baseline levels, sarcopenic patients (vs. non-sarcopenic) showed decreased prealbumin on postoperative day (POD) 1, decreased albumin on PODs 1, 3, and 5, and delayed recovery of lymphocyte counts (all P < 0.05). The levels of C-reactive protein in sarcopenic patients was lower than in non-sarcopenic patients on POD 1 (P = 0.010) but higher on POD 5 (P = 0.001). Multivariate analyses demonstrated the independent predictive value of sarcopenia for overall complications (P < 0.001), major complications (Clavien-Dindo grade ≥ III, P = 0.001), and delayed hospital discharge (>12 days, P < 0.001). Sarcopenia was demonstrated as a risk factor for deteriorated global QOL (P = 0.001), physical (P = 0.001) and role functions (P = 0.006), and severe fatigue (P = 0.004) at four weeks after surgery.
Sarcopenia was associated with poor metabolic stress and immune responses surrounding esophagectomy and was a potential target for reducing complications and promoting recovery of QOL.
由于回顾性研究设计和单一肌肉质量评估的限制,研究对于肌肉减少症对食管癌手术结果的影响提供了有争议和有限的知识。本前瞻性队列研究旨在解决这些问题。
在手术前进行生物电阻抗分析、握力测量和 4 米步行测试。诊断肌肉减少症为四肢骨骼肌质量指数低(男性<7.0kg/m,女性<5.7kg/m)加上握力低(男性<26kg,女性<18kg)和/或步行速度低(<0.8m/s)。预肌减少症诊断为:(1)仅肌肉质量指数低;或(2)仅握力和/或步行速度低。终点包括围手术期生化指标、术后并发症和术后生活质量(QOL)的恢复情况。
共纳入 212 例患者,其中 55 例(25.9%)和 60 例(28.3%)患者分别诊断为肌肉减少症和预肌减少症。预肌减少症和正常患者的术后并发症风险相似,因此将其合并。尽管基线水平相似,但肌肉减少症患者(与非肌肉减少症患者相比)在术后第 1 天(POD1)时白蛋白减少,在 POD1、3 和 5 时白蛋白减少,淋巴细胞计数恢复延迟(均 P<0.05)。肌肉减少症患者的 C 反应蛋白水平在 POD1 时低于非肌肉减少症患者(P=0.010),但在 POD5 时高于非肌肉减少症患者(P=0.001)。多变量分析表明肌肉减少症对总并发症(P<0.001)、主要并发症(Clavien-Dindo 分级≥III,P=0.001)和延迟出院(>12 天,P<0.001)有独立的预测价值。肌肉减少症是术后 4 周时总体生活质量(P=0.001)、身体(P=0.001)和角色功能(P=0.006)以及严重疲劳(P=0.004)恶化的危险因素。
肌肉减少症与食管癌围手术期代谢应激和免疫反应不良有关,是降低并发症发生率和促进生活质量恢复的潜在靶点。